Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

Immunotherapy has revolutionized the treatment paradigm of non-small cell lung cancer and improved patients’ prognosis. Immune checkpoint inhibitors have quickly become standard frontline treatment for metastatic non-oncogene addicted disease, either as a single agent or in combination strategies. H...

Full description

Bibliographic Details
Main Authors: Marco Russano, Giulia La Cava, Alessio Cortellini, Fabrizio Citarella, Alessandro Galletti, Giuseppina Rita Di Fazio, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Iacopo Fioroni, Francesco Pantano, Giuseppe Tonini, Bruno Vincenzi
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Current Oncology
Subjects:
immunotherapy
non-small cell lung cancer
immune checkpoint inhibitors
PD-1/PD-L1 antibodies
combination strategies
biomarkers
Online Access:https://www.mdpi.com/1718-7729/30/2/181

Internet

https://www.mdpi.com/1718-7729/30/2/181

Similar Items